These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 28435086)

  • 1. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
    Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
    J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.
    Zainul NH; Ma ZF; Besari A; Siti Asma H; Rahman RA; Collins DA; Hamid N; Riley TV; Lee YY
    Epidemiol Infect; 2017 Oct; 145(14):3012-3019. PubMed ID: 28891459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
    Sofjan AK; Islam MA; Halder K; Kabir ND; Saleh AA; Miranda J; Lancaster C; Begum K; Alam MJ; Garey KW
    Anaerobe; 2020 Feb; 61():102081. PubMed ID: 31356958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains.
    Almutairi MS; Gonzales-Luna AJ; Alnezary FS; Fallatah SB; Alam MJ; Begum K; Garey KW
    Anaerobe; 2021 Dec; 72():102440. PubMed ID: 34461273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced surveillance of Clostridium difficile infection occurring outside hospital, England, 2011 to 2013.
    Fawley WN; Davies KA; Morris T; Parnell P; Howe R; Wilcox MH;
    Euro Surveill; 2016 Jul; 21(29):. PubMed ID: 27487436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colonization of Toxigenic
    Mi H; Bao R; Xiao Y; Cui Y; Sun W; Shen Y; Shi Q; Chen X; Lin J; Hu B; Gao X
    Front Cell Infect Microbiol; 2020; 10():12. PubMed ID: 32083021
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains.
    Stoesser N; Eyre DW; Quan TP; Godwin H; Pill G; Mbuvi E; Vaughan A; Griffiths D; Martin J; Fawley W; Dingle KE; Oakley S; Wanelik K; Finney JM; Kachrimanidou M; Moore CE; Gorbach S; Riley TV; Crook DW; Peto TEA; Wilcox MH; Walker AS;
    PLoS One; 2017; 12(8):e0182307. PubMed ID: 28813461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribotype variability of Clostridioides difficile strains in patients with hospital-acquired C. difficile infections, community-acquired C. difficile infections, and colonization with toxigenic and non-toxigenic strains of C. difficile.
    Kim B; Seo MR; Kim J; Pai H
    Anaerobe; 2019 Dec; 60():102086. PubMed ID: 31404682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection: monoclonal or polyclonal genesis?
    Hell M; Permoser M; Chmelizek G; Kern JM; Maass M; Huhulescu S; Indra A; Allerberger F
    Infection; 2011 Oct; 39(5):461-5. PubMed ID: 21826436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium difficile infection in an Iranian hospital.
    Jalali M; Khorvash F; Warriner K; Weese JS
    BMC Res Notes; 2012 Mar; 5():159. PubMed ID: 22436392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.
    Dai W; Yang T; Yan L; Niu S; Zhang C; Sun J; Wang Z; Xia Y
    BMC Infect Dis; 2020 Apr; 20(1):277. PubMed ID: 32293302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile as a cause of healthcare-associated diarrhoea among children in Auckland, New Zealand: clinical and molecular epidemiology.
    Sathyendran V; McAuliffe GN; Swager T; Freeman JT; Taylor SL; Roberts SA
    Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1741-7. PubMed ID: 24810967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia?
    Hawkey PM; Marriott C; Liu WE; Jian ZJ; Gao Q; Ling TK; Chow V; So E; Chan R; Hardy K; Xu L; Manzoor S
    J Clin Microbiol; 2013 Oct; 51(10):3308-13. PubMed ID: 23903542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, England.
    Cairns MD; Preston MD; Lawley TD; Clark TG; Stabler RA; Wren BW
    J Clin Microbiol; 2015 Oct; 53(10):3141-7. PubMed ID: 26179308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospital-based Clostridium difficile infection surveillance reveals high proportions of PCR ribotypes 027 and 176 in different areas of Poland, 2011 to 2013.
    Pituch H; Obuch-Woszczatyński P; Lachowicz D; Wultańska D; Karpiński P; Młynarczyk G; van Dorp SM; Kuijper EJ;
    Euro Surveill; 2015; 20(38):. PubMed ID: 26536049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.
    Nicholas A; Kim YK; Lee WK; Selasi GN; Na SH; Kwon HI; Kim YJ; Lee HS; Song KE; Shin JH; Lee JC
    PLoS One; 2017; 12(3):e0174716. PubMed ID: 28355266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.
    Dubberke ER; Reske KA; Seiler S; Hink T; Kwon JH; Burnham CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4533-43. PubMed ID: 25987626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Observational Cohort Study of
    Rao K; Higgins PDR; Young VB
    mSphere; 2018; 3(3):. PubMed ID: 29794054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.